Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IOT 022

Next Previous
X
Search
Drug Profile

IOT 022

Alternative Names: IOT-022

Latest Information Update: 04 Jul 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Inorbit Therapeutics AB
  • Class Hepatoprotectants; Small molecules
  • Mechanism of Action Farnesoid X-activated receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Non-alcoholic steatohepatitis

Most Recent Events

  • 27 Jun 2022 IOT 022 is available for licensing as of 27 Jun 2022. https://inorbittx.com/investors/
  • 21 Jun 2022 Inorbit Therapeutics AB plans a phase I clinical trial for Non-alcoholic steatohepatitis in the quarter I of 2025
  • 21 Jun 2022 Inorbit Therapeutics AB has patent protection for farnesoid X receptors in the US, China, EU and South-Korea

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top